Literature DB >> 18570977

A case of *-fetoprotein-producing pulmonary carcinoma with restricted expression of hepatocyte nuclear factor-4* in hepatoid foci: a case report with studies of previous cases.

Takashi Kishimoto1, Tomoyuki Yano, Kenzo Hiroshima, Yoshiaki Inayama, Kae Kawachi, Yukio Nakatani.   

Abstract

We report a case of *-fetoprotein (AFP)-producing pulmonary carcinoma with studies for messenger RNA (mRNA) expression of hepatocyte nuclear factor (HNF)-4*, which is a transcription factor that is highly expressed in the process of liver development. The patient was a 64-year-old man with a pulmonary tumor in his left lower lobe. Serum AFP was 673 ng/mL. The microscopic analysis of the surgical specimen revealed a large cell neuroendocrine carcinoma with occasional hepatoid foci. The competitive reverse transcriptase polymerase chain reaction analysis revealed that HNF-4* mRNA was expressed on the order of 10(2)- to 10(3)-fold more abundantly than control pulmonary carcinomas and normal lung tissues. In addition, AFP and HNF-4* expression was restricted in hepatoid foci. Two previously reported cases of AFP-producing pulmonary carcinoma were also positive, whereas all 18 control pulmonary carcinomas were negative for HNF-4*. These findings suggest that aberrant expression of HNF-4* is implicated in the emergence or maintenance of hepatoid foci in AFP-producing pulmonary carcinomas.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18570977     DOI: 10.1016/j.humpath.2007.12.013

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  9 in total

1.  Src tyrosine kinase phosphorylation of nuclear receptor HNF4α correlates with isoform-specific loss of HNF4α in human colon cancer.

Authors:  Karthikeyani Chellappa; Lucy Jankova; Jake M Schnabl; Songqin Pan; Yann Brelivet; Caroline L-S Fung; Charles Chan; Owen F Dent; Stephen J Clarke; Graham R Robertson; Frances M Sladek
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

Review 2.  Merged hepatopulmonary features in hepatoid adenocarcinoma of the lung: a systematic review.

Authors:  Jia-Xi Mao; Cong Liu; Yuan-Yu Zhao; Guo-Shan Ding; Ji-Qing Ma; Fei Teng; Wen-Yuan Guo
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

3.  Hepatoid Adenocarcinoma of the Lung: A Systematic Review of the Literature From 1981 to 2020.

Authors:  Zan Hou; Jiaqing Xie; Li Zhang; Gangyi Dai; Yuanhang Chen; Lang He
Journal:  Front Oncol       Date:  2021-08-06       Impact factor: 6.244

4.  Primary Hepatoid Adenocarcinoma of the Lung: A Systematic Literature Review.

Authors:  Zhitao Chen; Chenchen Ding; Ting Zhang; Yahui He; Guoping Jiang
Journal:  Onco Targets Ther       Date:  2022-06-01       Impact factor: 4.345

5.  Hepatoid adenocarcinoma of the lung without production of α-fetoprotein: A case report and review of the literature.

Authors:  Ji Ning Sun; Bao Long Zhang; Lin Kun Li; Hai Yan Yu; Bin Wang
Journal:  Oncol Lett       Date:  2016-05-13       Impact factor: 2.967

Review 6.  Primary pulmonary hepatoid adenocarcinoma: A case report and review of the literature.

Authors:  Kun Yang; Huifeng Jiang; Qiuyao Li
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

Review 7.  Hepatoid adenocarcinoma of the lung: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database.

Authors:  Lei Lei; Liu Yang; Yang-Yang Xu; Hua-Fei Chen; Ping Zhan; Wen-Xian Wang; Chun-Wei Xu
Journal:  Open Med (Wars)       Date:  2021-01-22

8.  Hepatoid adenocarcinoma of the lung mimicking metastatic hepatocellular carcinoma.

Authors:  Yu Miyama; Takeshi Fujii; Kyoko Murase; Hisashi Takaya; Fukuo Kondo
Journal:  Autops Case Rep       Date:  2020-04-02

9.  Soft-Tissue Localization of Hepatoid Adenocarcinoma: First Case Report.

Authors:  Francesca Fornasa
Journal:  Case Rep Oncol       Date:  2010-07-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.